LY 451395,
LY-451395,
LY451395,
N-((2-(4'-(2-(methylsulfonyl)amino)ethyl)(1,1'-biphenyl)-4-yl)propyl)-2-propanesulfonamide,
MIBAMPATOR,
375345-95-2,
LY451395,
LY 451395,
LY-451395,
UNII-A9V5BW73UU,
A9V5BW73UU,
CHEMBL1277001,
N-[(2R)-2-[4-[4-[2-(methylsulfonylamino)ethyl]phenyl]phenyl]propyl]propane-2-sulfonamide,
2-Propanesulfonamide, N-((2R)-2-(4'-(2-((methylsulfonyl)amino)ethyl)(1,1'-biphenyl)-4-yl)propyl)-,
2-PROPANESULFONAMIDE, N-[(2R)-2-[4'-[2-[(METHYLSULFONYL)AMINO]ETHYL][1,1'-BIPHENYL]-4-YL]PROPYL]-,
Mibampator [USAN:INN],
Mibampator (USAN/INN),
SCHEMBL3045499,
CTK4H8360,
KS-00001CUC,
DTXSID20190977,
C21H30N2O4S2,
ZINC593414,
BCP28335,
2941AH,
BDBM50330415,
MFCD18251566,
CS-3166,
DB12717,
N-((2R)-2-(4'-(2-((Methylsulfonyl)amino)ethyl)biphenyl-4-yl)propyl)propane-2-sulfonamide,
NCGC00390642-01,
HY-10934,
QC-11706,
J3.560.858C,
D09931,
(R)-N-(2-(4''-(2-(methylsulfonamido)ethyl)biphenyl-4-yl)propyl)propane-2-sulfonamide,
(R)-N-(2-(4'-(2-(Methylsulfonamido)ethyl)-[1,1'-biphenyl]-4-yl)propyl)propane-2-sulfonamide,
8SO,
D01WBD,
CID9889366,
LY-450108,
AMPA agonists (Alzheimer's Disease), Lilly,
B4658,
AMPA receptor agonist (agitation in Alzheimer's Disease), Eli Lilly,
N-[2-[4-[4-(2-methanesulfonamidoethyl)phenyl]phenyl]propyl]propane-2-sulfonamide,